Metraipolis › archive › dc_2aa4471cf8aa

Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer — Europe PMC PMID:41201834

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41201834
DOI
10.1158/1078-0432.ccr-25-3033
License (as archived)
solo-consultazione
Archived
2026-11-07T03:56:06.617Z
SHA-256 of the archived text
25cb0376ff049e05576f9f2bd6ea14e535f0ab4f0aa58eaf8b090f464a0ef4e8
Stable URL of this page
https://metraipolis.com/documento/dc_2aa4471cf8aa

How to cite

Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer — Europe PMC PMID:41201834 — Europe PMC (en), https://europepmc.org/article/MED/41201834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2aa4471cf8aa (Metraipolis archive dc_2aa4471cf8aa, sha256 25cb0376ff049e05576f9f2bd6ea14e535f0ab4f0aa58eaf8b090f464a0ef4e8)
BibTeX
@misc{dc2aa4471cf8aa,
  title = {Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer — Europe PMC PMID:41201834},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41201834},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2aa4471cf8aa; sha256 25cb0376ff049e05576f9f2bd6ea14e535f0ab4f0aa58eaf8b090f464a0ef4e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41201834. Agents can read the archived copy with the MCP tool read_document.